Rab dysregulation affects the regulation of multiple signaling pathways by disrupting membrane trafficking and therefore plays a driving role in diseases such as cancer, neurological disorders, and several other genetic disorders (Menasche et al., 2000; Wasmeier et al., 2006; Giannandrea et al., 2010; Li, 2011). This evidence concerns the gene AGFG1 and nervous system disorder.